These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11438169)

  • 41. Neonatal androgenization affects the intrathymic T-cell maturation in rats.
    Leposavić G; Pejcić-Karapetrović B; Kosec D
    Neuroimmunomodulation; 2005; 12(2):117-30. PubMed ID: 15785114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
    Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
    Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
    Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion and recovery of lymphoid subsets following morphine administration.
    Zhang EY; Xiong J; Parker BL; Chen AY; Fields PE; Ma X; Qiu J; Yankee TM
    Br J Pharmacol; 2011 Dec; 164(7):1829-44. PubMed ID: 21557737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visceral chemical nociception in mice lacking mu-opioid receptors: effects of morphine, SNC80 and U-50,488.
    Sora I; Li XF; Funada M; Kinsey S; Uhl GR
    Eur J Pharmacol; 1999 Feb; 366(2-3):R3-5. PubMed ID: 10082217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenocorticotropin stress response but not glucocorticoid-negative feedback is altered by prenatal morphine exposure in adult male rats.
    Rimanóczy A; Slamberová R; Riley MA; Vathy I
    Neuroendocrinology; 2003 Dec; 78(6):312-20. PubMed ID: 14688444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal.
    Zhou Y; Bendor J; Hofmann L; Randesi M; Ho A; Kreek MJ
    J Endocrinol; 2006 Oct; 191(1):137-45. PubMed ID: 17065397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid is involved in food-entrainable rhythm of mu-opioid receptor expression in mouse brainstem and analgesic effect of morphine.
    Yoshida M; Kiyofuji H; Koyanagi S; Matsuo A; Fujioka T; To H; Higuchi S; Ohdo S
    J Pharmacol Sci; 2006 May; 101(1):77-84. PubMed ID: 16682786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linomide enhances apoptosis in CD4+CD8+ thymocytes.
    Harring AC; Xu Z; Andersson G; Hedlund G
    Scand J Immunol; 1997 Nov; 46(5):488-94. PubMed ID: 9393631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine.
    Rauhut AS; Gehrke BJ; Phillips SB; Bardo MT
    Pharmacol Biochem Behav; 2002 Oct; 73(3):611-22. PubMed ID: 12151036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diurnal alteration in opiate effects on the hypothalamo-pituitary-adrenal axis: changes in the mechanism of action.
    Kiem DT; Fekete MI; Makara GB
    Eur J Pharmacol; 1995 Jan; 272(2-3):145-50. PubMed ID: 7713158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X; Geller EB; Adler MW
    Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
    Gavériaux-Ruff C; Matthes HW; Peluso J; Kieffer BL
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6326-30. PubMed ID: 9600964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.